Traversing Higher Hurdles For Functional Limitations Under Section 112 | MoFo Life Sciences

Genus claims have long been an important component of patent strategy, extending coverage around a lead compound to stop would-be competitors. Recent decisions from the Federal Circuit,...

Related Keywords

Japan , ,Janssen Biotech Inc ,Amgen Inc ,Mofo Life Sciences ,Abbvie Deutschland Gmbh Co ,Harvard Journal Of Law Technology ,Mofo Life ,Federal Circuit ,Genus Claim ,Harvard Journal ,Abbvie Deutschland Gmbh ,